Privia Health Group Inc.

NASDAQ: PRVA · Real-Time Price · USD
21.21
0.50 (2.41%)
At close: Aug 15, 2025, 12:17 PM

Privia Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.9B 1.8B 1.74B 1.72B 1.7B 1.69B 1.66B 1.58B 1.51B 1.43B 1.36B 1.27B 1.18B 1.07B 966.22M 904.59M 860.23M 817.74M
Cost of Revenue
1.71B 1.62B 1.56B 1.55B 1.53B 1.52B 1.5B 1.42B 1.36B 1.29B 1.22B 1.14B 1.06B 997.94M 902.56M 842.41M 802.72M 729.9M
Gross Profit
186.74M 181.76M 176.85M 167.93M 164.31M 163.06M 161.5M 159.17M 151.32M 143.73M 134.78M 122.96M 115.22M 68.47M 63.66M 62.17M 57.52M 87.84M
Operating Income
19.61M 21.38M 16.98M 13.15M 12.88M 14.76M 20.65M 21.48M 11.37M -861K -19.12M -40.72M -48.95M -236.89M -217.44M -193.93M -172.57M 26.79M
Interest Income
7.5M 5.09M 5.15M 5.15M 5.88M 5.88M 2.89M 4.05M 1.44M 1.44M 1.44M 285K n/a n/a n/a n/a n/a n/a
Pretax Income
29.89M 32.21M 27.87M 24.12M 24.57M 24.3M 29.02M 28.15M 15.44M 1.73M -18.58M -41.51M -50.33M -237.9M -218.51M -195.25M -174.11M 25.05M
Net Income
14.84M 15.62M 14.38M 12.82M 14.93M 18.74M 23.08M 38.02M 32.93M 15.18M -10.23M -39.98M -49.66M -211.72M -188.23M -172.39M -146.59M 31.23M
Selling & General & Admin
161.6M 153.04M 152.6M 147.56M 144.29M 141.29M 134.32M 131.8M 134.64M 139.8M 149.33M 159.13M 160.32M 302.23M 278.63M 254.29M 228.29M 59.1M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
5.53M 7.35M 7.27M 7.21M 7.14M 7.01M 6.53M 5.9M 5.32M 306.49M 306.27M 306.24M 305.56M 3.14M 2.46M 1.8M 1.8M 1.95M
Operating Expenses
167.13M 160.39M 159.87M 154.77M 151.43M 148.3M 140.85M 137.69M 139.96M 144.59M 153.9M 163.67M 164.18M 305.36M 281.1M 256.1M 230.09M 61.05M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a 285K 948K 1.18M 1.36M 1.37M 1.01M 1.07M 1.32M 1.53M 1.74M
Selling & Marketing Expenses
27.24M 27.28M 26.45M 26.23M 26.43M 25.53M 24.73M 23.66M 21.5M 20.37M 19.74M 18.37M 17.87M 24.23M 22.75M 22.91M 21.03M 12.07M
Cost & Expenses
1.88B 1.78B 1.72B 1.7B 1.68B 1.67B 1.64B 1.56B 1.5B 1.43B 1.38B 1.31B 1.23B 1.3B 1.18B 1.1B 1.03B 790.95M
Income Tax Expense
11.21M 12.18M 10.83M 10.12M 8.6M 6.62M 7.99M -7.4M -14.73M -10.7M -6.52M -712K 1.92M -23.55M -27.86M -20.27M -26.62M -6.14M
Shares Outstanding (Basic)
122.13M 120.62M 120.14M 119.66M 119.3M 118.51M 118.11M 117.6M 116.16M 115.01M 114.36M 124.85M 108.69M 108.06M 107.03M 101.28M 102.74M 103.9M
Shares Outstanding (Diluted)
128.45M 127.75M 126.42M 125.75M 125.32M 125.05M 124.83M 124.92M 124.57M 124.33M 124.14M 124.85M 108.69M 108.06M 107.03M 105.9M 102.74M 103.9M
EPS (Basic)
0.12 0.13 0.13 0.11 0.13 0.16 0.19 0.33 0.28 0.13 -0.1 -0.37 -0.47 -2.05 -1.83 -1.68 -1.43 0.30
EPS (Diluted)
0.12 0.12 0.11 0.10 0.12 0.15 0.19 0.31 0.26 0.11 -0.12 -0.37 -0.46 -2.05 -1.82 -1.68 -1.43 0.30
EBITDA
30.14M 28.73M 24.25M 20.36M 20.02M 21.77M 27.18M 27.37M 16.69M 3.93M -14.55M -36.17M -45.09M -233.75M -214.97M -192.12M -170.78M 28.74M
EBIT
22.02M 21.38M 16.98M 13.15M 12.88M 14.76M 20.65M 22.63M 12.52M 291K -17.97M -40.72M -48.95M -236.89M -217.44M -193.93M -172.57M 26.79M
Depreciation & Amortization
8.11M 7.35M 7.27M 7.21M 7.14M 7.01M 6.53M 5.9M 5.32M 4.79M 4.57M 4.55M 3.86M 3.14M 2.46M 1.8M 1.79M 1.95M